Literature DB >> 25135597

Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies.

A A J M van de Ven1, W J M Janssen, L S Schulz, A M van Loon, K Voorkamp, E A M Sanders, J G Kusters, S Nierkens, M Boes, A M J Wensing, J M van Montfrans.   

Abstract

PURPOSE: Gastrointestinal disease occurs frequently in antibody deficiencies. This study aims to explore the relation between gastrointestinal infections and mucosal homeostasis in patients with antibody deficiencies.
METHODS: We performed an observational study including 54 pediatric antibody deficient patients (48 % CVID, 41 % CVID-like, 11 % XLA) and 66 healthy controls. Clinical symptom scores and stool samples were collected prospectively. Stool samples were evaluated for bacteria, parasites, viruses, secretory IgA- and for calprotectin levels. Results were compared between patients and controls.
RESULTS: 24 % of antibody deficient patients versus 9 % of healthy controls tested positive for gastrointestinal viruses (p = 0.028). Fecal calprotectin levels were significantly higher in virus positive patients compared to virus negative patients (p = 0.002). However, in controls, fecal calprotectin levels were similar between virus positive and virus negative controls. Moreover, gastrointestinal virus positive patients had low serum IgA levels in 13/14 cases (94 %) versus 40/62 (62 %) patients in the virus negative patient group (p = 0.04). The virus positive patient group also displayed significantly lower secretory IgA levels in stool (median 13 ug/ml) than patients without gastrointestinal viruses detected or healthy controls (median 155 ug/ml) (p = 0.046).
CONCLUSION: We here report an increased prevalence of gastrointestinal viruses and gastrointestinal complaints in antibody deficient patients. Patients that tested positive for gastrointestinal viruses showed diminished serum- and secretory IgA levels, and only in patients, virus positivity was associated with signs of mucosal inflammation. These findings suggest that particularly patients with low IgA are at risk for longstanding replication of gastrointestinal viruses, which may eventually result in CVID-related enteropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135597     DOI: 10.1007/s10875-014-0087-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

Review 2.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

3.  Progression of selective IgA deficiency to common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Javad Mohammadi; Nima Parvaneh; Nima Rezaei; Mostafa Moin; Teresa Espanol; Lennart Hammarstrom
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

4.  Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease.

Authors:  Shradha Agarwal; Paul Smereka; Noam Harpaz; Charlotte Cunningham-Rundles; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

Review 5.  Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.

Authors:  N J Mantis; N Rol; B Corthésy
Journal:  Mucosal Immunol       Date:  2011-10-05       Impact factor: 7.313

6.  The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease.

Authors:  Georgia Malamut; Virginie Verkarre; Felipe Suarez; Jean-François Viallard; Anne-Sophie Lascaux; Jacques Cosnes; Yoram Bouhnik; Olivier Lambotte; Dominique Béchade; Marianne Ziol; Anne Lavergne; Olivier Hermine; Nadine Cerf-Bensussan; Christophe Cellier
Journal:  Am J Gastroenterol       Date:  2010-06-15       Impact factor: 10.864

7.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

8.  Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.

Authors:  A G Røseth; P N Schmidt; M K Fagerhol
Journal:  Scand J Gastroenterol       Date:  1999-01       Impact factor: 2.423

9.  Adult autoimmune enteropathy: Mayo Clinic Rochester experience.

Authors:  Salma Akram; Joseph A Murray; Darrell S Pardi; Glenn L Alexander; John A Schaffner; Pierre A Russo; Susan C Abraham
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-01       Impact factor: 11.382

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  11 in total

1.  Association between interleukin-2, interleukin-10, secretory immunoglobulin A and immunoglobulin G expression in vaginal fluid and human papilloma virus outcome in patients with cervical lesions.

Authors:  Jing-Wei Meng; Jing-Hui Song
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

Review 2.  Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

3.  RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies.

Authors:  Cristina Contini; Davide Firinu; Simone Serrao; Barbara Manconi; Alessandra Olianas; Francesco Cinetto; Fausto Cossu; Massimo Castagnola; Irene Messana; Stefano Del Giacco; Tiziana Cabras
Journal:  J Clin Immunol       Date:  2020-01-08       Impact factor: 8.317

Review 4.  Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).

Authors:  Mathieu Uzzan; Huaibin M Ko; Saurabh Mehandru; Charlotte Cunningham-Rundles
Journal:  Curr Gastroenterol Rep       Date:  2016-04

5.  Immune/microbial interface perturbation in human IgA deficiency.

Authors:  Delphine Sterlin; Claire Fieschi; Marion Malphettes; Martin Larsen; Guy Gorochov; Jehane Fadlallah
Journal:  Gut Microbes       Date:  2018-11-18

6.  CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont.

Authors:  Natalia Shulzhenko; Xiaoxi Dong; Dariia Vyshenska; Renee L Greer; Manoj Gurung; Stephany Vasquez-Perez; Ekaterina Peremyslova; Stanislav Sosnovtsev; Martha Quezado; Michael Yao; Kim Montgomery-Recht; Warren Strober; Ivan J Fuss; Andrey Morgun
Journal:  Clin Immunol       Date:  2018-09-19       Impact factor: 3.969

Review 7.  Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

Authors:  Dominic Paquin-Proulx; Johan K Sandberg
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

8.  Bowel Histology of CVID Patients Reveals Distinct Patterns of Mucosal Inflammation.

Authors:  Cornelia M van Schewick; David M Lowe; Siobhan O Burns; Sarita Workman; Andrew Symes; David Guzman; Fernando Moreira; Jennifer Watkins; Ian Clark; Bodo Grimbacher
Journal:  J Clin Immunol       Date:  2021-10-01       Impact factor: 8.542

9.  Immunodeficiency Promotes Adaptive Alterations of Host Gut Microbiome: An Observational Metagenomic Study in Mice.

Authors:  Shuyu Zheng; Tingting Zhao; Shuijuan Yuan; Lingyu Yang; Jinmei Ding; Li Cui; Mingqing Xu
Journal:  Front Microbiol       Date:  2019-11-01       Impact factor: 5.640

10.  Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea.

Authors:  Cornelia M van Schewick; Christina Nöltner; Svenja Abel; Siobhan O Burns; Sarita Workman; Andrew Symes; David Guzman; Michele Proietti; Alla Bulashevska; Fernando Moreira; Veronika Soetedjo; David M Lowe; Bodo Grimbacher
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.